Please assess the completion status of the following clinical trial:

Trial Title: Trial of the Treatment of Chronic Laryngitis With Amitryptiline

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18 or older and able to consent for themselves.~* Structural pathology such as tumor previously ruled out using flexible laryngoscopy.~* Able to speak and read the English language.~* Failed a trial of a proton pump inhibitor for the treatment of gastopharyngeal reflux.~* Women under 55 years of age who may become pregnant must have a negative pregnancy test and agree to barrier or hormonal methods of contraception during the study.~Exclusion Criteria:~* Environmental allergies.~* Smoking within past 5 years.~* Using ginko bilboa (or unwilling to cease using it).~* Current upper respiratory infections.~* Use of narcotics (e.g. oxycodone, methadone).~* Any prior history of amitryptiline use.~* Use of monoamine oxidase inhibitors (MAOIs) within the past 4 weeks (selegiline, phenelzine, tranylcypromine, isocarboxazid, rasagiline, phenelzine sulfate, selegiline hydrochloride, rasagiline mesylate, tranylcypromine sulfate).~* History of urinary retention.~* Any history of major depressive disorder.~* Any prior history of allergy to a tricyclic antidepressant.~* Current diagnosis of gastroesophageal reflux (GERD).~* For women 18-55 years of age without history of menopause: currently nursing or pregnant, plans to become pregnant, or unwillingness to utilize contraception (barrier or hormonal methods).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 64 Years
- Healthy Volunteers: f

Study Arms:
- amitriptyline (Type: EXPERIMENTAL): Subjects in this arm will receive pills composed of amitryptline and Avicel (cellulose filler)
- Placebo (Type: PLACEBO_COMPARATOR): Subjects in this arm will receive pills composed only of Avicel (cellulose filler)

Based on this trial design, predict the completion outcome and termination type (if applicable).